| Irfan Maqbool Khurram, MD | |
|
315 W State St, Doylestown, PA 18901-3525 | |
| (215) 345-1900 | |
| (215) 345-4579 |
| Full Name | Irfan Maqbool Khurram |
|---|---|
| Gender | Male |
| Speciality | Cardiac Electrophysiology |
| Experience | 23 Years |
| Location | 315 W State St, Doylestown, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538229612 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Doylestown Hospital | Doylestown, PA | Hospital |
| Grand View Hospital | Sellersville, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Via Affiliates | 1759295512 | 182 |
News Archive
NeoPharm, Inc. today announced the results of a Phase II clinical trial of Liposome-Entrapped Paclitaxel (LEP) an active component of Taxol®. This multicenter, open-label trial of LEP was conducted at 5 centers in India.
University of Montana researcher Angela Luis has been awarded a National Science Foundation grant to study how diversity of competitor species affects infectious disease transmission in wildlife – specifically hantavirus in deer mice.
GlaxoSmithKline confirmed today that a joint advisory committee to the U.S. Food and Drug Administration (FDA) voted to allow Avandia to remain on the market. Committee members voted for recommendations ranging from making no changes to the current label, to revising the label with additional warnings and restrictions to withdrawal from the U.S. market.
The malaria parasite has waged a successful guerrilla war against the human immune system for eons, but a study in this week's Journal of Biological Chemistry has exposed one of the tricks malaria uses to hide from the immune proteins, which may aid in future drug development.
"Having passed the Violence Against Women Act (VAWA) in Congress, despite attempts to block it by extreme conservatives, the United States has demonstrated its commitment to ending gender-based violence at home and can now support the world's efforts to do the same," contributor Chloë Cooney writes in the RH Reality Check blog.
› Verified 5 days ago
| Entity Name | Via Affiliates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003446261 PECOS PAC ID: 1759295512 Enrollment ID: O20031117000104 |
News Archive
NeoPharm, Inc. today announced the results of a Phase II clinical trial of Liposome-Entrapped Paclitaxel (LEP) an active component of Taxol®. This multicenter, open-label trial of LEP was conducted at 5 centers in India.
University of Montana researcher Angela Luis has been awarded a National Science Foundation grant to study how diversity of competitor species affects infectious disease transmission in wildlife – specifically hantavirus in deer mice.
GlaxoSmithKline confirmed today that a joint advisory committee to the U.S. Food and Drug Administration (FDA) voted to allow Avandia to remain on the market. Committee members voted for recommendations ranging from making no changes to the current label, to revising the label with additional warnings and restrictions to withdrawal from the U.S. market.
The malaria parasite has waged a successful guerrilla war against the human immune system for eons, but a study in this week's Journal of Biological Chemistry has exposed one of the tricks malaria uses to hide from the immune proteins, which may aid in future drug development.
"Having passed the Violence Against Women Act (VAWA) in Congress, despite attempts to block it by extreme conservatives, the United States has demonstrated its commitment to ending gender-based violence at home and can now support the world's efforts to do the same," contributor Chloë Cooney writes in the RH Reality Check blog.
› Verified 5 days ago
| Entity Name | Temple Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942444088 PECOS PAC ID: 2062317233 Enrollment ID: O20040310000054 |
News Archive
NeoPharm, Inc. today announced the results of a Phase II clinical trial of Liposome-Entrapped Paclitaxel (LEP) an active component of Taxol®. This multicenter, open-label trial of LEP was conducted at 5 centers in India.
University of Montana researcher Angela Luis has been awarded a National Science Foundation grant to study how diversity of competitor species affects infectious disease transmission in wildlife – specifically hantavirus in deer mice.
GlaxoSmithKline confirmed today that a joint advisory committee to the U.S. Food and Drug Administration (FDA) voted to allow Avandia to remain on the market. Committee members voted for recommendations ranging from making no changes to the current label, to revising the label with additional warnings and restrictions to withdrawal from the U.S. market.
The malaria parasite has waged a successful guerrilla war against the human immune system for eons, but a study in this week's Journal of Biological Chemistry has exposed one of the tricks malaria uses to hide from the immune proteins, which may aid in future drug development.
"Having passed the Violence Against Women Act (VAWA) in Congress, despite attempts to block it by extreme conservatives, the United States has demonstrated its commitment to ending gender-based violence at home and can now support the world's efforts to do the same," contributor Chloë Cooney writes in the RH Reality Check blog.
› Verified 5 days ago
| Entity Name | Temple Faculty Practice Plan Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881176949 PECOS PAC ID: 0345588711 Enrollment ID: O20190208002623 |
News Archive
NeoPharm, Inc. today announced the results of a Phase II clinical trial of Liposome-Entrapped Paclitaxel (LEP) an active component of Taxol®. This multicenter, open-label trial of LEP was conducted at 5 centers in India.
University of Montana researcher Angela Luis has been awarded a National Science Foundation grant to study how diversity of competitor species affects infectious disease transmission in wildlife – specifically hantavirus in deer mice.
GlaxoSmithKline confirmed today that a joint advisory committee to the U.S. Food and Drug Administration (FDA) voted to allow Avandia to remain on the market. Committee members voted for recommendations ranging from making no changes to the current label, to revising the label with additional warnings and restrictions to withdrawal from the U.S. market.
The malaria parasite has waged a successful guerrilla war against the human immune system for eons, but a study in this week's Journal of Biological Chemistry has exposed one of the tricks malaria uses to hide from the immune proteins, which may aid in future drug development.
"Having passed the Violence Against Women Act (VAWA) in Congress, despite attempts to block it by extreme conservatives, the United States has demonstrated its commitment to ending gender-based violence at home and can now support the world's efforts to do the same," contributor Chloë Cooney writes in the RH Reality Check blog.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Irfan Maqbool Khurram, MD Po Box 829641, Philadelphia, PA 19182-0001 Ph: (267) 370-5295 | Irfan Maqbool Khurram, MD 315 W State St, Doylestown, PA 18901-3525 Ph: (215) 345-1900 |
News Archive
NeoPharm, Inc. today announced the results of a Phase II clinical trial of Liposome-Entrapped Paclitaxel (LEP) an active component of Taxol®. This multicenter, open-label trial of LEP was conducted at 5 centers in India.
University of Montana researcher Angela Luis has been awarded a National Science Foundation grant to study how diversity of competitor species affects infectious disease transmission in wildlife – specifically hantavirus in deer mice.
GlaxoSmithKline confirmed today that a joint advisory committee to the U.S. Food and Drug Administration (FDA) voted to allow Avandia to remain on the market. Committee members voted for recommendations ranging from making no changes to the current label, to revising the label with additional warnings and restrictions to withdrawal from the U.S. market.
The malaria parasite has waged a successful guerrilla war against the human immune system for eons, but a study in this week's Journal of Biological Chemistry has exposed one of the tricks malaria uses to hide from the immune proteins, which may aid in future drug development.
"Having passed the Violence Against Women Act (VAWA) in Congress, despite attempts to block it by extreme conservatives, the United States has demonstrated its commitment to ending gender-based violence at home and can now support the world's efforts to do the same," contributor Chloë Cooney writes in the RH Reality Check blog.
› Verified 5 days ago
Andrew E Krick, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 310 Farm Lane, Doylestown, PA 18901 Phone: 215-348-3990 Fax: 215-348-7705 | |
Sherilyn Lisa Tittermary Mccollum, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1456 Ferry Road, Suite 403, Doylestown, PA 18901 Phone: 267-483-8094 Fax: 267-483-8312 | |
Dr. George Wiemann, M.D, FACC Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 315 W State St, Doylestown, PA 18901 Phone: 215-345-1900 Fax: 215-345-4579 | |
Marvin Ralph Gordon, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 4740 Dickinson Way, Doylestown, PA 18902 Phone: 215-794-2528 Fax: 267-544-0105 | |
Christopher P Hermann, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 301s Main St, Ste 2w, Doylestown, PA 18901 Phone: 215-348-4800 Fax: 215-348-4350 | |
Mr. Les A Szekely, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2003 Lower State Rd Unit 110, Doylestown, PA 18901 Phone: 215-348-1310 Fax: 215-348-8615 | |
Venu Pasricha, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 595 W State St, Doylestown, PA 18901 Phone: 215-345-2885 Fax: 215-345-2552 |